UK markets open in 1 hour 15 minutes

Xtant Medical Holdings, Inc. (XMS.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.6000-0.0150 (-2.44%)
At close: 08:04AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 83.77M
Enterprise value 106.02M
Trailing P/E 45.73
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.87
Price/book (mrq)1.83
Enterprise value/revenue 1.14
Enterprise value/EBITDA 32.03

Trading information

Stock price history

Beta (5Y monthly) 0.33
52-week change 32.50%
S&P500 52-week change 324.52%
52-week high 31.2800
52-week low 30.5850
50-day moving average 30.7763
200-day moving average 30.9827

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5130.22M
Implied shares outstanding 6136.21M
Float 840.11M
% held by insiders 18.30%
% held by institutions 169.40%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -1.64%
Operating margin (ttm)-12.45%

Management effectiveness

Return on assets (ttm)-9.58%
Return on equity (ttm)-4.14%

Income statement

Revenue (ttm)101.23M
Revenue per share (ttm)0.81
Quarterly revenue growth (yoy)55.30%
Gross profit (ttm)N/A
EBITDA -8.34M
Net income avi to common (ttm)-1.66M
Diluted EPS (ttm)0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.55M
Total cash per share (mrq)0.04
Total debt (mrq)28.76M
Total debt/equity (mrq)60.32%
Current ratio (mrq)2.34
Book value per share (mrq)0.37

Cash flow statement

Operating cash flow (ttm)-13.03M
Levered free cash flow (ttm)-26.91M